Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:47:58.603Z.
Calculation as of: 2026-10-06T18:47:58.603Z.
Quote observation: 2026-10-06T18:45:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 05c00b329f1e3adc6cfa9751fac96b44e9956e0cda8839801cbe896438e656e1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-11-03.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Syndax Pharmaceuticals, Inc.
Market Cap
$1.54B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.53B
EV/EBITDA Ratio
4.33x
TTM Avg
3.71x
3Y Avg
17.44x
5Y Avg
17.91x
Market Cap
$1.51B
EV/EBITDA Ratio
72.66x
TTM Avg
329.18x
3Y Avg
230.60x
5Y Avg
237.22x
Market Cap
$1.57B
EV/EBITDA Ratio
N/A
TTM Avg
37.36x
3Y Avg
37.36x
5Y Avg
37.36x
Market Cap
$1.49B
EV/EBITDA Ratio
8.85x
TTM Avg
11.44x
3Y Avg
12.12x
5Y Avg
11.37x
Market Cap
$1.47B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.61B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.54B | N/A | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 4.92x | 69.99x | 32.98x | 22.10x |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 4.33x | 3.71x | 17.44x | 17.91x |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 72.66x | 329.18x | 230.60x | 237.22x |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | N/A | 37.36x | 37.36x | 37.36x |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 8.85x | 11.44x | 12.12x | 11.37x |
| uniQure N.V. (QURE)vs › | $1.61B | N/A | 1.92x | 1.94x | 1.94x |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.47B | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2022-11-03 | 967.45x |
| 2022-11-02 | 993.65x |
| 2022-11-01 | 1004.88x |
| 2022-10-31 | 996.92x |
| 2022-10-28 | 1032.47x |
| 2022-10-27 | 997.39x |
| 2022-10-26 | 1006.75x |
| 2022-10-25 | 1008.62x |
| 2022-10-24 | 1012.83x |
| 2022-10-21 | 1024.52x |
| 2022-10-20 | 970.73x |
| 2022-10-19 | 955.29x |
| 2022-10-18 | 1015.63x |
| 2022-10-17 | 1039.96x |
| 2022-10-14 | 1023.59x |
| 2022-10-13 | 1045.57x |
| 2022-10-12 | 1060.07x |
| 2022-10-11 | 1020.31x |
| 2022-10-10 | 1022.18x |
| 2022-10-07 | 1055.86x |
| 2022-10-06 | 1150.36x |
| 2022-10-05 | 1079.72x |
| 2022-10-04 | 1090.01x |
| 2022-10-03 | 1051.19x |
| 2022-09-30 | 1046.98x |
| 2022-09-29 | 1078.78x |
| 2022-09-28 | 1069.90x |
| 2022-09-27 | 1015.63x |
| 2022-09-26 | 991.78x |
| 2022-09-23 | 995.99x |
| 2022-09-22 | 989.91x |
| 2022-09-21 | 1014.70x |
| 2022-09-20 | 1029.67x |
| 2022-09-19 | 999.73x |
| 2022-09-16 | 1005.34x |
| 2022-09-15 | 1072.24x |
| 2022-09-14 | 1039.49x |
| 2022-09-13 | 1020.31x |
| 2022-09-12 | 1034.35x |
| 2022-09-09 | 1072.24x |
| 2022-09-08 | 1082.53x |
| 2022-09-07 | 1012.83x |
| 2022-09-06 | 995.05x |
| 2022-09-02 | 1057.27x |
| 2022-09-01 | 1079.72x |
| 2022-08-31 | 1027.33x |
| 2022-08-30 | 1009.09x |
| 2022-08-29 | 990.84x |
| 2022-08-26 | 1000.67x |
| 2022-08-25 | 1053.06x |
| 2022-08-24 | 1072.70x |
| 2022-08-23 | 1069.43x |
| 2022-08-22 | 1048.38x |
| 2022-08-19 | 1074.57x |
| 2022-08-18 | 1052.59x |
| 2022-08-17 | 1055.86x |
| 2022-08-16 | 1079.72x |
| 2022-08-15 | 1080.19x |
| 2022-08-12 | 1045.57x |
| 2022-08-11 | 1029.67x |
| 2022-08-10 | 1045.57x |
| 2022-08-09 | 1045.10x |
| 2022-08-08 | 75.39x |
| 2022-08-05 | 73.95x |
| 2022-08-04 | 69.83x |
| 2022-08-03 | 63.82x |
| 2022-08-02 | 61.95x |
| 2022-08-01 | 61.67x |
| 2022-07-29 | 61.64x |
| 2022-07-28 | 64.34x |
| 2022-07-27 | 64.66x |
| 2022-07-26 | 63.85x |
| 2022-07-25 | 64.49x |
| 2022-07-22 | 63.01x |
| 2022-07-21 | 59.84x |
| 2022-07-20 | 57.21x |
| 2022-07-19 | 57.45x |
| 2022-07-18 | 56.19x |
| 2022-07-15 | 56.96x |
| 2022-07-14 | 57.31x |
| 2022-07-13 | 57.45x |
| 2022-07-12 | 56.68x |
| 2022-07-11 | 55.09x |
| 2022-07-08 | 58.33x |
| 2022-07-07 | 59.53x |
| 2022-07-06 | 61.64x |
| 2022-07-05 | 61.64x |
| 2022-07-01 | 57.06x |
| 2022-06-30 | 57.66x |
| 2022-06-29 | 57.10x |
| 2022-06-28 | 55.17x |
| 2022-06-27 | 55.80x |
| 2022-06-24 | 57.28x |
| 2022-06-23 | 56.78x |
| 2022-06-22 | 52.25x |
| 2022-06-21 | 51.44x |
| 2022-06-17 | 49.22x |
| 2022-06-16 | 45.60x |
| 2022-06-15 | 47.08x |
| 2022-06-14 | 45.39x |
| 2022-06-13 | 44.86x |
| 2022-06-10 | 47.57x |
| 2022-06-09 | 50.35x |
| 2022-06-08 | 52.25x |
| 2022-06-07 | 49.64x |
| 2022-06-06 | 46.20x |
| 2022-06-03 | 47.96x |
| 2022-06-02 | 48.38x |
| 2022-06-01 | 48.27x |
| 2022-05-31 | 48.03x |
| 2022-05-27 | 47.39x |
| 2022-05-26 | 43.38x |
| 2022-05-25 | 41.52x |
| 2022-05-24 | 39.83x |
| 2022-05-23 | 41.20x |
| 2022-05-20 | 41.55x |
| 2022-05-19 | 38.60x |
| 2022-05-18 | 37.97x |
| 2022-05-17 | 41.45x |
| 2022-05-16 | 39.30x |
| 2022-05-13 | 39.62x |
| 2022-05-12 | 39.06x |
| 2022-05-11 | 38.53x |
| 2022-05-10 | 43.24x |
| 2022-05-09 | 22.67x |
| 2022-05-06 | 24.62x |
| 2022-05-05 | 25.68x |
| 2022-05-04 | 27.48x |
| 2022-05-03 | 26.98x |
| 2022-05-02 | 26.84x |
| 2022-04-29 | 26.00x |
| 2022-04-28 | 26.30x |
| 2022-04-27 | 25.16x |
| 2022-04-26 | 25.06x |
| 2022-04-25 | 25.94x |
| 2022-04-22 | 25.30x |
| 2022-04-21 | 25.80x |
| 2022-04-20 | 26.80x |
| 2022-04-19 | 26.42x |
| 2022-04-18 | 26.84x |
| 2022-04-14 | 28.74x |
| 2022-04-13 | 29.20x |
| 2022-04-12 | 27.44x |
| 2022-04-11 | 27.88x |
| 2022-04-08 | 27.48x |
| 2022-04-07 | 30.10x |
| 2022-04-06 | 30.78x |
| 2022-04-05 | 31.42x |
| 2022-04-04 | 30.70x |
| 2022-04-01 | 27.70x |
| 2022-03-31 | 27.22x |
| 2022-03-30 | 26.96x |
| 2022-03-29 | 28.96x |
| 2022-03-28 | 27.12x |
| 2022-03-25 | 27.66x |
| 2022-03-24 | 28.08x |
| 2022-03-23 | 27.66x |
| 2022-03-22 | 28.46x |
| 2022-03-21 | 26.36x |
| 2022-03-18 | 25.88x |
| 2022-03-17 | 26.06x |
| 2022-03-16 | 26.60x |
| 2022-03-15 | 24.62x |
| 2022-03-14 | 24.00x |
| 2022-03-11 | 26.16x |
| 2022-03-10 | 27.42x |
| 2022-03-09 | 27.08x |
| 2022-03-08 | 26.46x |
| 2022-03-07 | 25.40x |
| 2022-03-04 | 22.96x |
| 2022-03-03 | 24.64x |
| 2022-03-02 | 24.68x |
